SIC
CDAK

Salem Investment Counselors’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Salem Investment Counselors’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50
Closed -$9 – 1210
2023
Q1 		$9 Hold
50
– – ﹤0.01% 1114
2022
Q4 		$20 Hold
50
– – ﹤0.01% 1086
2022
Q3 		$0 Hold
50
– – ﹤0.01% 1153
2022
Q2 		$0 Hold
50
– – ﹤0.01% 1147
2022
Q1 		$0 Hold
50
– – ﹤0.01% 1145
2021
Q4 		$1K Hold
50
– – ﹤0.01% 1057
2021
Q3 		$1K Hold
50
– – ﹤0.01% 955
2021
Q2 		$1K Buy
+50
New +$960 ﹤0.01% 884

Salem Investment Counselors's CDAK Position: Q2 2023 in Review

Salem Investment Counselors sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 50 shares — an estimated $9 sold.

Salem Investment Counselors first reported a position in CDAK in Q2 2021 and held it in 8 quarters. The position peaked at $1K in Q4 2021. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

  • Salem Investment Counselors reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 50 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $9.
  • Salem Investment Counselors first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Salem Investment Counselors's Codiak BioSciences, Inc. Common Stock position peaked at $1K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Salem Investment Counselors's 13F filing for Q2 2023, filed 19 Jul 2023.